Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.

1. The effects of an oral platelet activating factor (PAF) antagonist, BN52063, or matched placebo on inhaled PAF challenge were assessed in a double-blind study in eight normal subjects. 2. PAF (24 micrograms) induced an immediate bronchoconstriction, with a maximum fall in flow at 30% of vital cap...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Roberts, N M, McCusker, M, Chung, K F, Barnes, P J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1988
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1386501/
https://ncbi.nlm.nih.gov/pubmed/3203062
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak